Navigation Links
AIDS expert says global strategy needed to combat feminization of HIV/AIDS

Thomas C. Quinn, M.D., a Johns Hopkins physician and scientist, who has spent the best part of the last 25 years leading major efforts to combat HIV and AIDS throughout the world, is calling for global strategies and resources to confront the rapid "feminization" of the AIDS pandemic.

Quinn, a professor of infectious diseases at Hopkins and a senior investigator at the National Institute of Allergy and Infectious Disease, reports that women have in the last 20 years moved from being those least affected by HIV to those in whom the disease is spreading fastest.

According to Quinn women now make up nearly half of the 40 million people worldwide currently infected with HIV, the virus that causes AIDS, and in some developing countries, women represent the vast majority of those living with HIV/AIDS.

At the start of the pandemic in the early 1980s, men accounted for almost 90 percent of cases in developed countries. In the United States from 1999 to 2003, the yearly increase in AIDS cases rose by 15 percent, but only by 1 percent in men.

He says that now AIDS is having the most profound impact on women.

Internationally, Quinn and his team are renowned for leading clinical trials of the first effective treatments that prevent HIV from replicating, and helping to establish laboratory and treatment facilities in the Democratic Republic of the Congo, India and Uganda, and counselling other governments across Africa and Asia about control efforts.

Now he argues that because of the increasing and disproportionate numbers becoming infected, and the social consequences of so many young mothers dying and leaving behind children who may also be infected as well as orphaned, women deserve a separate strategy.

He also points out that medical research suggests hormonal and developmental factors place young women at greater risk than men for contracting the virus when exposed to it.

60 percent of people living with HIV in
'"/>

Source:News-Medical Net


Page: 1 2 3

Related biology news :

1. South Americas vast pantanal wetland may become next everglades, UNU experts warn
2. Hopkins AIDS experts issue warning about global efforts to provide drug therapies
3. Crisis in African fish supplies looms, experts warn Africa leaders
4. Infectious disease expert warns of spread of Rocky Mountain spotted fever
5. Tsunami + 1 year: Reviving exhausted fisheries should trump replacing boats, gear, experts say
6. Johns Hopkins flu expert calls for mandatory vaccination of health care workers
7. Evidence for omega 3 fats less conclusive than we thought, say experts
8. Medical experts: US unlikely to have enough vaccines to stop avian flu
9. Deep-rooted plants have much greater impact on climate than experts thought
10. Climate experts search for answers in the oceans
11. Comments, experts and background on the 2006 Nobel Prize in chemistry

Post Your Comments:
(Date:11/24/2009)...akened and flabby arteries from collapsing have be...tents are no longer needed -- once the arteries ar...y, doctors had no choice but to leave them in plac...ty,s Department of Biomedical Engineering has deve...ries drugs where they,re needed, then dissolves. ,...
(Date:11/24/2009)...rctica has long held secrets of the earth,s histor...ere has been very little information on the enviro...for millions of years. Now, a team of researchers ...unded to the tune of $10 million dollars by the Na...ottom of things literally. These scientists will ...
(Date:11/23/2009)...rch presents strong evidence that the "synergistic...affic-related pollution and indoor endotoxin cause...her exposure alone. , Environmental health sci...ge of Medicine have shown that children exposed to... indoor endotoxin during early life are six times ...
Breaking Biology News(10 mins):A coating for life 2LSU gets to the bottom of things -- in Antarctica 2Exposure to both traffic, indoor pollutants puts some kids at higher risk for asthma later 2Vyvanse Capsules CII administration through 2 routes demonstrated similar pharmacokinetic profile 59967 1Vyvanse Capsules CII administration through 2 routes demonstrated similar pharmacokinetic profile 59967 2Vyvanse Capsules CII administration through 2 routes demonstrated similar pharmacokinetic profile 59967 3Rotavirus Vaccine Cutting Infection Rates Among Kids 59964 1Rotavirus Vaccine Cutting Infection Rates Among Kids 59964 2Syphilis survey reveals need for accurate testing for early infection 59960 1
...r an important and longstanding question about the...tients have high levels of a brain protein because...ear it from their brains quickly enough? , Resear... (ADRC) at Washington University School of Medicin...ensitive way to monitor the production and clearan...
...ered that a recently identified protein critical f...sm to keep its repairs accurate. , The protein, ... proteins known as DNA polymerases that are vital ...while other DNA-repair proteins insure their accur...ns or accessory molecules, this protein maintains ...
...asbro Children’s Research Center and Brown Medical...atest risk for HIV. Amongst a group of high-risk t... for the disease (those who engaged in the most un...ental health problems. , Prior studies have found ...h mental health issues and other high-risk behavio...
Other Biology News:Production of key Alzheimer's protein monitored for first time in humans 2Production of key Alzheimer's protein monitored for first time in humans 3Unusual mechanism keeps repair protein accurate 2Unusual mechanism keeps repair protein accurate 3New HIV study identifies high-risk subgroups of adolescents 2New HIV study identifies high-risk subgroups of adolescents 3
(Date:11/23/2009)...3/PRNewswire/--Frost&Sullivan,theGrowthPartner...tingleadershipandinnovationThursday,November19,200...theldinSanAntonio,Texas. ,, (Logo: http://www.n...eHealthcareInnovationAwardsaregiventocompaniesthat...nagementofhealthcare.Suchcompanieshaveshownsuccess...
(Date:11/23/2009)...re-FirstCall/--CornerstoneTherapeuticsInc.(Nasdaq:...quiring,developingandcommercializingsignificantpro...odayannouncedthatCraigA.Collard,PresidentandChiefE...atthe21stAnnualPiperJaffrayHealthCareConferenceat3...eHotelinNewYorkCity. ,, Aliveaudioandarchivedwe...
(Date:11/20/2009)...ies have an opportunity to take the lead in two sm...iversity of Valencia (UV), working together with t... fabric of the Spanish biotechnology industry. The...rs have more clout than those in English-speaking ...d plants has been overlooked by the leading countr...
(Date:11/20/2009)...ewswire-FirstCall/ -- Dendreon Corporation (Nasdaq...rug Administration (FDA) provided written acknowle...se Application (BLA) for PROVENGE® (sipuleuce... a Prescription Drug User Fee Act (PDUFA) date of ...reon,s amended BLA. Dendreon is seeking licensure...
Breaking Biology Technology:Excellence in Healthcare Innovation Recognized by Frost & Sullivan 2Excellence in Healthcare Innovation Recognized by Frost & Sullivan 3Cornerstone Therapeutics to Present at the 21st Annual Piper Jaffray Health Care Conference 2Spanish biotechnology should focus on food and plant sectors to be more competitive 2Dendreon Receives FDA Acknowledgement of Complete Response 2Dendreon Receives FDA Acknowledgement of Complete Response 3
...l 25 CV Therapeutics,Inc. (Nasdaq: CVTX ) today ...nded March 31, 2008., For the quarter ended March...9 million, or $0.53 per share. This compares to a ... the prior quarter ended December 31, 2007,and $55...er in 2007., For the quarter ended March 31, 2008...
...ntists and Collaborators Publish Study in Science,...bH, the,leading developer of RAFT intervention the...per in Science demonstrating a potential novel str...and other diseases by targeting,discrete sub-compa...nducted,by JADO scientists together with several a...
...lif., April 24 ,Exelixis, Inc. (Nasdaq: EXEL ) an...t and chief executive officer of Exelixis, will pr...ugged Conference at 3:40 p.m. ET/12:40,p.m. PT on ...s updates to,the company,s development pipeline an...ebcast and may be accessed in the Event,Calendar p...
Other Biology Technology:CV Therapeutics Reports 2008 First Quarter Financial Results 2CV Therapeutics Reports 2008 First Quarter Financial Results 3CV Therapeutics Reports 2008 First Quarter Financial Results 4CV Therapeutics Reports 2008 First Quarter Financial Results 5Novel Approach to Treat Alzheimer's and Other Diseases Offered by Targeting Cell Membrane RAFTS 2Novel Approach to Treat Alzheimer's and Other Diseases Offered by Targeting Cell Membrane RAFTS 3Novel Approach to Treat Alzheimer's and Other Diseases Offered by Targeting Cell Membrane RAFTS 4
Rabbit Anti-NMDAR1 C2' Polyclonal Antibody, Unconjugated from Abcam
Rabbit Anti-Coronin / CORO1C Polyclonal Antibody, Unconjugated from IMGENEX
Rabbit Anti-Human Retinoic Acid-Induced 3 (RAI3 / RAIG1) Polyclonal Antibody, Unconjugated from IMGENEX
GIBCO Sf-900 Medium (1.3X) liquid from Invitrogen
Biology Products: